Lichen Planus

Boch, K., Langan, E.A.; Kridin, K.;et al.Lichen Planus. Front. Med. 2021;8:737813.

Tziotzios, C.; Lee, J.Y.W.; Brier, T.;et al. Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis. J. Am. Acad. Dermatol. 2018;79:789-804.

Alrashdan, M.S.; Cirillo, N.; McCullough, M. Oral lichen planus: A literature review and update. Arch. Dermatol. Res. 2016;308:539–551.

Solimani, F.; Forchhammer, S.; Schloegl, A.; et al.Lichen planus-a clinical guide. J. Dtsch. Dermatol. Ges. 2021;19: 864–882.

Ujiie, H.; Rosmarin, D.; Schon, M.P.; et al. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. Front. Med. 2022;9:875492.

Nosratzehi, T. Oral lichen planus: An overview of potential risk factors, biomarkers and treatments. Asian Pac. J. Cancer Prev. 2018;19:1161–1167.

Netto, J.N.S.; Pires, F.R.; Costa, K.H.A.; Fischer, R.G. Clinical features of oral lichen planus and oral lichenoid lesions: An oral pathologist’s perspective. Braz. Dent. J. 2022;33:67-73.

Fechine, C.O.C.; Valente, N.Y.S.; Romiti, R. Lichen planopilaris and frontal fibrosing alopecia: Review and update of diagnostic and therapeutic features. An. Bras. Dermatol.2022;97:348–357.

Gupta, M.K.; Lipner, S.R. Review of Nail Lichen Planus: Epidemiology, Pathogenesis, Diagnosis, and Treatment. Dermatol. Clin. 2021;39: 221–230.

Schruf, E.; Biermann, M.H.; Jacob, J.; et al. Lichen planus in Germany-epidemiology, treatment, and comorbidity. A retrospective claims data analysis. J. Dtsch. Dermatol. Ges. 2022; 20:1101–1110.

Fromme, M.; Schneider, C.V.; Schlapbach, C.;et al. Comorbidities in lichen planus by phenome-wide association study in two biobank population cohorts. Br. J. Dermatol. 2022;187:722–729.

Fertig, R.M.; Hu, S.; Maddy, A.J.; et al. Medical comorbidities in patients with lichen planopilaris, a retrospective case-control study. Int. J. Dermatol. 2018;57:804–809.

Fan, R.; Leasure, A.C.; Cohen, J.M. Association of autoimmune comorbidities with lichen planus: A United State-based case-control study in the All of Us research program. J. Am. Acad. Dermatol. 2022;87:1451–1453.

De Porras-Carrique, T.; Ramos-Garcia, P.; Aguilar-Diosdado, M.; Warnakulasuriya, S.; Gonzalez-Moles, M.A. Autoimmune disorders in oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2022.

MohanKumar, K.P.; Nachiammai, N.; Madhushankari, G.S. Association of oral manifestations in ulcerative colitis: A pilot study. J. Oral Maxillofac. Pathol. 2018;22:199–203.

Garcia-Pola, M.J.; Llorente-Pendas, S.; Seoane-Romero, J.M.; et al. Thyroid disease and oral lichen planus as comorbidity: A prospective case-control study. Dermatology 2016;232:214–219.

Darlenski, R.; Mihaylova, V.; Handjieva-Darlenska, T. The Link Between Obesity and the Skin. Front. Nutr. 2022;9:855573.

Daye, M.; Temiz, S.A.; Isik, B. The relationship between lichen planus and metabolic syndrome. J. Cosmet. Dermatol. 2021;20:2635–2639.

Leasure, A.C.; Acosta, J.N.; Sansing, L.H.; et al.Association of lichen planus with cardiovascular disease: A combined analysis of the UK Biobank and All of Us Study. J. Am. Acad. Dermatol. 2022;87: 454–456.

De Porras-Carrique, T.; Gonzalez-Moles, M.A.; Warnakulasuriya, S.; Ramos-Garcia, P. Depression, anxiety, and stress in oral lichen planus: A systematic review and meta-analysis. Clin. Oral Investig. 2022;26:1391–1408.

Liao, H.; Luo, Y.; Long, L.;et al. Anxiety and oral lichen planus. Oral Dis. 2021;27:506–514.

Hsu, D.Y.; Chien, W.C.; Chung, C.H.; et al. Risk of anxiety and depression in patients with lichen planus: A nationwide population-based study. J. Affect. Disord. 2022;300:255–262.

Fiocco, Z.; Kupf, S.; Patzak, L.; et al. Quality of Life and Psychopathology in Lichen Planus: A Neglected Disease Burden. Acta Derm. Venereol. 2021;101: adv00619.

Brănişteanu, D.E.; Pintilie, A.; Andreş, L.E.;et al. Ethiopatogenic hypotheses in lichen planus.pdf. Rev. Med. Chir. Soc. Med. Nat. Iasi 2016;120:760–767.

Liu, J.; Ye, Z.; Mayer, J.G.; et al. Phenome-wide association study maps new diseases to the human major histocompatibility complex region. J. Med. Genet. 2016;53:681–689.

Nagao, Y.; Nishida, N.; Toyo-Oka, L.;et al.Genome-Wide Association Study Identifies Risk Variants for Lichen Planus in Patients with Hepatitis C Virus Infection. Clin. Gastroenterol. Hepatol. 2017;15:937–944.e5.

Ma, S.H.; Tai, Y.H.; Dai, Y.X.; et al.Association between hepatitis C virus infection and subsequent chronic inflammatory skin disease. J. Dermatol. 2021;48:1884–1891.

Alaizari, N.A.; Al-Maweri, S.A.; Al-Shamiri, H.M.; et al.Hepatitis C virus infections in oral lichen planus: A systematic review and meta-analysis. Aust. Dent. J. 2016;61:282–287.

Petti, S.; Rabiei, M.; De Luca, M.; Scully, C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: Meta-analysis and case control study. Odontology 2011;99:168–178.

Lodi, G.; Pellicano, R.; Carrozzo, M. Hepatitis C virus infection and lichen planus: A systematic review with meta-analysis. Oral Dis. 2010;16:601–612.

Pitak-Arnnop, P.; Subbalekha, K.; Sirintawat, N.; et al. Are oral lichen planus patients at high risk of hepatitis C? A case-control study. J. Stomatol. Oral Maxillofac. Surg. 2022;123: e37–e42.

Georgescu, S.R.; Tampa, M.; Mitran, M.I.; et al. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection. Exp. Ther. Med. 2019; 17:1045–1051.

Di Stasio, D.; Lucchese, A.; Romano, A.; et al.The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: A cohort study. Clin. Oral Investig. 2022; 26:5409–5417.

Della Vella, F.; Lauritano, D.; Pannone, G.; et al. Prevalence of HPV in patients affected by oral Lichen planus: A prospective study using two different chair-side sampling methods. J. Oral Pathol. Med. 2021;50:716–722.

Nahidi, Y.; Tayyebi Meibodi, N.; Ghazvini, K.; et al.Association of classic lichen planus with human herpesvirus-7 infection. Int. J. Dermatol. 2017;56:49–53.

De Vries, H.J.; van Marle, J.; Teunissen, M.B.;et al.Lichen planus is associated with human herpesvirus type 7 replication and infiltration of plasmacytoid dendritic cells. Br. J. Dermatol. 2006;154:361–364.

De Vries, H.J.; Teunissen, M.B.; Zorgdrager, F.;et al. Lichen planus remission is associated with a decrease of human herpes virus type 7 protein expression in plasmacytoid dendritic cells. Arch. Dermatol. Res. 2007;299:213–219.

Wang, J.H.; Hung, S.J. Lichen planus associated with hepatitis B, hepatitis C, and liver cirrhosis in a nationwide cohort study. J. Am. Acad. Dermatol. 2021;84:1085–1086.

Cozzani, E.; Herzum, A.; Burlando, M.; Parodi, A. Cutaneous manifestations of HAV, HBV, HCV. Ital. J. Dermatol. Venerol. 2021;156:5–12.

Mizukawa, Y.; Horie, C.; Yamazaki, Y.; Shiohara, T. Detection of varicella-zoster virus antigens in lesional skin of zosteriform lichen planus but not in that of linear lichen planus. Dermatology 2012;225:22–26.

Ashraf, S.; Al-Maweri, S.A.; Alaizari, N.;et al. The association between Epstein-Barr virus and oral lichen planus: A systematic review and meta-analysis. J. Oral Pathol. Med. 2020;49::969–976.

Zou, H.;Daveluy,S.Licken planus after COVID-19 infection and vaccination.Arch Dermatol Res.2023;315:139-146.

Lahouel, M.; Aounallah, A.; Mokni, S.;et al. Severe childhood lichen planus pemphigoides after hepatitis A vaccination. Skin Health Dis. 2022;2: e94.

Calista, D.; Morri, M. Lichen planus induced by hepatitis B vaccination: A new case and review of the literature. Int. J. Dermatol. 2004; 43:562–564.

Lai, Y.C.; Yew, Y.W. Lichen planus and lichenoid drug eruption after vaccination. Cutis 2017;100:E6–E20.

Torre, K.; Grant-Kels, J.M.; Oliviero, M.; Rabinovitz, H. Lichen planus eruption following annual influenza vaccination. JAAD Case Rep. 2021;10:116–118.

An, I.; Demir, V.; İbiloğlu, İ.; Akdeniz, S. Lichen planus secondary to rabies vaccination. Dermatol. Online J. 2017;23:13030.

Rosengard, H.C.; Wheat, C.M.; Tilson, M.P.; Cuda, J.D. Lichen planus following tetanus-diphtheria-acellular pertussis vaccination: A case report and review of the literature. SAGE Open Med. Case Rep. 2018;6:2050313X17750335.

Awada, B.; Abdullah, L.; Kurban, M.; Abbas, O. Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine. J. Cosmet. Dermatol. 2022;21:883–885.

Diab, R.; Araghi, F.; Gheisari, M.; et al. Lichen planus and lichen planopilaris flare after COVID-19 vaccination. Dermatol. Ther. 2022;35: e15283.

Herzum, A.; Burlando, M.; Molle, M.F.;et al. Lichen planus flare following COVID-19 vaccination: A case report. Clin. Case Rep. 2021;9:e05092.

Guarneri, C.; Ceccarelli, M.; Rinaldi, L.; et al.Helicobacter pylori and skin disorders: A comprehensive review of the available literature. Eur. Rev. Med. Pharmacol. Sci. 2020;24:12267–12287.

Li, S.; Zhang, Y.; Yang, Z.; et al.Helicobacter pylori infection is correlated with the incidence of erosive oral lichen planus and the alteration of the oral microbiome composition. BMC Microbiol. 2021;21:122.

Kazanowska-Dygdala, M.; Dus, I.; Radwan-Oczko, M. The presence of Helicobacter pylori in oral cavities of patients with leukoplakia and oral lichen planus. J. Appl. Oral Sci. 2016;24:18–23.

Lin, D.; Yang, L.; Wen, L.;et al. Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis. Mucosal. Immunol. 2021;14:1247–1258.

Ghone, U.; Sarode, G.S.; Sengupta, N.; Sarode, S.C. Are fungi responsible for the pathogenesis of oral lichen planus? Med. Hypotheses 2021;156:110689.

Zhong, E.F.; Chang, A.; Stucky, A.; et al.Genomic Analysis of Oral Lichen Planus and Related Oral Microbiome Pathogens. Pathogens 2020;9: 952.

Rasul, T.F.; Anderson, J.; Bergholz, D.R.; et al.Gold Dental Implant-Induced Oral Lichen Planus. Cureus 2022;14: e21852.

Belhareth, K.; Korbi, M.; Belhadjali, H.;et al.Pediatric lichen planus pigmentosus possibly triggered by mercury dental amalgams. Pediatr. Dermatol. 2020;37:375–376.

Thanyavuthi, A.; Boonchai, W.; Kasemsarn, P. Amalgam Contact Allergy in Oral Lichenoid Lesions. Dermatitis 2016;27:215–221.

Reichart, P.A.; Warnakulasuriya, S. Oral lichenoid contact lesions induced by areca nut and betel quid chewing: A mini review. J. Investig. Clin. Dent. 2012;3: 163–166.

Liu, W.; Yang, Y.; Zhang, X.; Shi, H. Oral potentially malignant disorder research in Taiwan and mainland China: A scientometric analysis. J. Dent. Sci. 2022;17:1854–1858.

Guillet, G.; Coindre, M.; Levillain, P.; Guillet, M.H. Lichenoid dermatitis resulting from sensitization to dimethylfumarate: Atypical presentation of “Chinese sofa dermatitis”. Ann. Dermatol. Venereol. 2009;136:279–281.

Ajaaouani, R.; Hali, F.; Marnissi, F.; et al.A Generalized Form of Lichen Planus Pemphigoid Induced by an Oral Antidiabetic. Cureus 2022;14:e31094.

Fessa, C.; Lim, P.; Kossard, S.; et al. Lichen planus-like drug eruptions due to β-blockers: A case report and literature review. Am. J. Clin. Dermatol. 2012;13: 417–421.

Baccino, D.; Merlo, G.; Cozzani, E.; et al.Cutaneous effects of antihypertensive drugs. G. Ital. Dermatol. Venereol. 2020;155: 202–211.

Yuyaem, T.; Sudchada, P.; Srisuttiyakorn, C.; et al.Ethambutol Induced Lichenoid Drug Eruption: A Case Report. Curr. Drug. Saf. 2021;16: 296–298.

Mastorino, L.; Ortoncelli, M.; Giura, M.T.; et al. Lichen ruber planus arising during dupilumab treatment for atopic dermatitis. Ital. J. Dermatol. Venerol. 2022;157:449–450.

Oliveira, S.C.; Vasconcelos, A.H.C.; Magalhaes, E.P.B.; et al. Clinical, Histopathological and Outcome Analysis of Five Patients with Lichenoid Eruption following Anti-Tumor Necrosis Factor-Alpha Therapy for Ankylosing Spondylitis: Report of One Case and Review of the Literature. Cureus 2020;12: e10598.

Shah, R.R.; Bhate, C.; Hernandez, A.; Ho, C.H. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab. Dermatol. Ther. 2022;35: e1543.

Kluger, N. Radiation-associated lichen planus: A case report and literature review. Acta Dermatovenerol. Alp. Pannonica Adriat. 2017;26:105–108.

Zhang, X.; Lei, L.; Jiang, L.;et al. Characteristics and pathogenesis of Koebner phenomenon. Exp. Dermatol. 2022:1–14.

Lim, A.; Tang, P.Y.; Oh, C.C. Lichen planus pemphigoides after body tattooing. J. Cosmet. Dermatol. 2020; 19:3048–3052.

Cerqueira, J.D.M.; Moura, J.R.; Arsati, F.; Lima-Arsati, Y.B.O.; Bittencourt, R.A.; Freitas, V.S. Psychological disorders and oral lichen planus: A systematic review. J. Investig. Clin. Dent. 2018; 9:e12363.

Chen, H.X.; Blasiak, R.; Kim, E.;et al.Triggers of oral lichen planus flares and the potential role of trigger avoidance in disease management. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2017;124:248–252.

Sufiawati, I.; Megawati, A.; Al Farisyi, M.; Putra, I. A Case Series of Psychological Stress Evaluation as a Risk Factor for Oral Lichen Planus. Case Rep. Dent. 2022;2022:1915122.

Geng, L.; Zhang, X.; Tang, Y.; Gu, W. Identification of Potential Key Biomarkers and Immune Infiltration in Oral Lichen Planus. Dis. Markers 2022;2022:7386895.

Vicic, M.; Kastelan, M.; Brajac, I.;et al. Current Concepts of Psoriasis Immunopathogenesis. Int. J. Mol. Sci. 2021;22:11574.

Pietschke, K.; Holstein, J.; Meier, K.;et al.The inflammation in cutaneous lichen planus is dominated by IFN-Upsilon and IL-21-A basis for therapeutic JAK1 inhibition. Exp. Dermatol. 2021;30: 262–270.

Mutafchieva, M.Z.; Draganova-Filipova, M.N.; Zagorchev, P.I.; Tomov, G.T. Oral lichen planus-known and unknown: A review. Folia Med. 2018;60:528–535.

Shiohara, T.; Moriya, N.; Tsuchiya, K.;et al.Lichenoid tissue reaction induced by local transfer of Ia-reactive T-cell clones. J. Investig. Dermatol. 1986;87:33-38

Nogueira, P.A.; Carneiro, S.; Ramos-e-Silva, M. Oral lichen planus: An update on its pathogenesis. Int. J. Dermatol. 2015;54:1005–1010.

El-Howati, A.; Thornhill, M.H.; Colley, H.E.; Murdoch, C. Immune mechanisms in oral lichen planus. Oral Dis. 2022;00:1–16.

Aghamajidi, A.; Raoufi, E.; Parsamanesh, G.;et al.The attentive focus on T cell-mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo. Scand. J. Immunol. 2021;93:e13000.

Husein-ElAhmed, H.; Steinhoff, M. Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: A systematic review with META-analysis. J. Eur. Acad. Dermatol. Venereol. 2022;36:1735–1744.

Georgescu, S.R.; Mitran, C.I.; Mitran, M.I.;et al.Oxidative Stress in Cutaneous Lichen Planus-A Narrative Review. J. Clin. Med. 2021;10: 2692.

Chitirala, P.; Ravichandran, K.; Galgano, D.;et al.Cytotoxic Granule Exocytosis From Human Cytotoxic T Lymphocytes Is Mediated by VAMP7. Front. Immunol. 2019;10:1855.

Vicic, M.; Sotosek, V.; Brajac, I.;et al. The possible involvement of granulysin mediated cytotoxicity in keratinocytes disruption in lichen planus. Med. Hypotheses 2021;149: 110546.

Vicic, M.; Brajac, I.; Kastelan, M.;et al. Elevated Granulysin Expression in Cytotoxic Lymphocytes from the Blood and Lesions of Patients with Lichen Planus. Acta Derm. Venereol. 2021;101: adv00499.

Vicic, M.; Kastelan, M.; Sotosek Tokmadzic, V.; Prpic Massari, L. Systemic and local increase of granulysin expression in cytotoxic lymphocytes in severe psoriasis. Acta Derm. Venereol. 2019;99:1136–1142.

Aggarwal, N.; Bhateja, S. Oral Lichen Planus-a Mucopigmentory Disorder. Biomed. J. Sci. Tech. Res. 2018;4:4234–4242.

Ryan, G.E.; Harris, J.E.; Richmond, J.M. Resident Memory T Cells in Autoimmune Skin Diseases. Front. Immunol. 2021;12:652191.

Zhou, L.; Cao, T.; Wang, Y.;et al. Frequently increased but functionally impaired CD4+CD25+ regulatory T cells in patients with oral lichen planus. Inflammation 2016;39:1205–1215.

Ramalingam, S.; Malathi, N.; Thamizhchelvan, H.;et al. Role of Mast Cells in Oral Lichen Planus and Oral Lichenoid Reactions. Autoimmune Dis. 2018;2018:7936564.

Shan, J.; Li, S.; Wang, C.;et al. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus. Exp. Dermatol. 2019;28:816–821.

Ferrisse, T.M.; de Oliveira, A.B.; Palacon, M.P.;et al. Immunohistochemical evaluation of Langerhans cells in oral lichen planus and oral lichenoid lesions. Arch. Oral Biol. 2021;124:105027.

Chandavarkar, V.; Mishra, M.N.; Sangeetha, R.; Premalatha, B.R. The Current Understanding on Langerhans’ Cells and Its Role in Oral Lesions. Contemp. Clin. Dent. 2020;11:211–216.

Kurago, Z.B. Etiology and pathogenesis of oral lichen planus: An overview. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016;122: 72–80.

DeAngelis, L.M.; Cirillo, N.; McCullough, M.J. The immunopathogenesis of oral lichen planus-Is there a role for mucosal associated invariant T cells? J. Oral Pathol. Med. 2019;48:552–559.

Zychowska, M.; Wozniak, Z.; Baran, W. Immunohistochemical analysis of the expression of selected cell lineage markers (CD4, CD8, CD68, c-Kit, Foxp3, CD56, CD20) in cutaneous variant of lichen planus. Int. J. Dermatol. 2021;60:1097–1101.

Ferrisse, T.M.; de Oliveira, A.B.; Palacon, M.P.;et al. The role of CD68+ and CD163+ macrophages in immunopathogenesis of oral lichen planus and oral lichenoid lesions. Immunobiology 2021;226: 152072.

Yang, J.Y.; Zhang, J.; Lu, R.;et al. T cell-derived exosomes induced macrophage inflammatory protein-1alpha/beta drive the trafficking of CD8(+) T cells in oral lichen planus. J. Cell Mol. Med. 2020; 24:14086–14098.

Flores-Hidalgo, A.; Murrah, V.; Fedoriw, Y.; Padilla, R.J. Relationship of infiltrating intraepithelial T lymphocytes in the diagnosis of oral lichen planus versus oral epithelial dysplasia: A pilot study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2019;127:e123–e135.

Sugerman, P.B.; Savage, N.W.; Zhou, X.;et al.Oral lichen planus. Clin. Dermatol. 2000;18:533–539.

Solimani, F.; Pollmann, R.; Schmidt, T.;et al.Therapeutic Targeting of Th17/Tc17 Cells Leads to Clinical Improvement of Lichen Planus. Front. Immunol. 2019;10: 1808.

Yang, J.Y.; Wang, F.; Zhou, G. Characterization and function of circulating mucosal-associated invariant T cells and γδT cells in oral lichen planus. J. Oral Pathol. Med. 2022;51:74–85.

Enomoto, A.; Sato, E.; Yasuda, T.;et al. Intraepithelial CD8+ lymphocytes as a predictive diagnostic biomarker for the remission of oral lichen planus. Hum. Pathol. 2018;74:43–53.

Mao, F.; Dong, Y.; Wang, Z.;et al.Direct immunofluorescence and immune function in patients with oral lichen planus. J. Dent. Sci. 2022;17: 795–801.

Lorenzini, G.; Viviano, M.; Chisci, E.;et al.A comparative immunohistochemical and immunophenotypical study on lymphocytes expression in patients affected by oral lichen planus. J. Oral Pathol. Med. 2013;42: 642–647.

Tan, Y.Q.; Li, Q.; Zhang, J.;et al. Increased circulating CXCR5(+) CD4(+) T follicular helper-like cells in oral lichen planus. J. Oral Pathol. Med. 2017;46: 803–809.

Pandiyan, P.; Zhu, J. Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine 2015;76:13–24.

Shen, Z.; Gao, X.; Ma, L.;et al. Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol. Res. 2014;306:441–446.

Xue, N.; Wang, Y.; Cheng, H.;et al.Regulatory T cell therapy suppresses inflammation of oral mucosa. Front. Immunol. 2022; 13: 1009742.

Carbone, T.; Nasorri, F.; Pennino, D.;et al.CD56 highCD16-NK cell involvement in cutaneous lichen planus. Eur. J. Dermatol. 2010; 20:724–730.

Ge, X.; Xie, H.; Wang, L.; Li, R.;et al.MicroRNA-122 promotes apoptosis of keratinocytes in oral lichen planus through suppressing VDR expression. J. Cell Mol. Med. 2021;25:3400–3407.

Yang, J.Y.; Tan, Y.Q.; Zhou, G. T cell-derived exosomes containing cytokines induced keratinocytes apoptosis in oral lichen planus. Oral Dis. 2022; 28: 682–690.

Khattab, F.M.; Ghonaim, R.; Samir, M.A. Estimation of neutrophil activation marker in lichen planus patients. J. Cosmet. Dermatol. 2022; 21: 1625–1628.

Jablonska, E.; Garley, M.; Surazynski, A.;et al. Neutrophil extracellular traps (NETs) formation induced by TGF-beta in oral lichen planus-Possible implications for the development of oral cancer. Immunobiology 2020; 225: 151901.

Carvalho, M.; Cavalieri, D.; Do Nascimento, S.;et al.Cytokines Levels and Salivary Microbiome Play A Potential Role in Oral Lichen Planus Diagnosis. Sci. Rep. 2019; 9: 18137.

Pekiner, F.N.; Demirel, G.Y.; Borahan, M.O.; Ozbayrak, S. Cytokine profiles in serum of patients with oral lichen planus. Cytokine 2012;60: 701–706.

Hu, J.Y.; Zhang, J.; Cui, J.L.;et al. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine 2013;62:141–145.

Barrat, F.J.; Crow, M.K.; Ivashkiv, L.B. Interferon target-gene expression and epigenomic signatures in health and disease. Nat. Immunol. 2019;20: 1574–1583.

Damsky, W.; Wang, A.; Olamiju, B.;et al. Treatment of severe lichen planus with the JAK inhibitor tofacitinib. J. Allergy Clin. Immunol. 2020;145:1708–1710.e2.

Yang, C.C.; Khanna, T.; Sallee, B.;et al. Tofacitinib for the treatment of lichen planopilaris: A case series. Dermatol. Ther. 2018;31:e12656.

Chen, J.F.; Zhang, X.M.; Sanjel, K.;et al. Expression and Significance of TNF-alpha and NF-kappaB/p65 in Cutaneous Lichen Planus. Clin. Cosmet. Investig. Dermatol. 2022;15:1509–1516.

Lu, R.; Zhang, J.; Sun, W.;et al. Inflammation-related cytokines in oral lichen planus: An overview. J. Oral Pathol. Med. 2015;44:1–14.

Zhu, Z.D.; Ren, X.M.; Zhou, M.M.;et al.Salivary cytokine profile in patients with oral lichen planus. J. Dent. Sci. 2022; 17: 100–105.

Negi, D.; Urs, A.B.; Kumar, P.;et al. Assessment of Interleukin-18 gene polymorphism and serum levels in oral lichen planus in an Indian population. J. Oral Pathol. Med. 2019;48:244–250.

Xu, X.H.; Liu, Y.; Feng, L.;et al.Interleukin-6 released by oral lichen planus myofibroblasts promotes angiogenesis. Exp. Ther. Med. 2021; 21: 291.

Mardani, M.; Mofidi, H.; Dastgheib, L.;et al.Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus. Mediat. Inflamm. 2021;2021:5578568.

Shen, Z.; Du, G.; Zhou, Z.;et al. Aberrant expression of interleukin-22 and its targeting microRNAs in oral lichen planus: A preliminary study. J. Oral Pathol. Med. 2016:45: 523–527.

Mardani, M.; Torabi Ardakani, S.; Dastgheib, L.; Hamidizadeh, N. Serum Levels of IL-22 in Patients with Oral Lichen Planus and Cutaneous Lichen Planus. J. Dent. 2020; 21: 330–334.

Zychowska, M.; Batycka-Baran, A.; Baran, W. Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases? Dis. Markers 2020;2020:6521274.

Wang, K.; Miao, T.; Lu, W.;et al. Analysis of oral microbial community and Th17-associated cytokines in saliva of patients with oral lichen planus. Microbiol. Immunol. 2015;59:105–113.

Zare, R.; Mohtasham, N.; Ghazi, N.;et al. Evaluation of correlation between transcription factors and IL-17 in oral and cutaneous lichen planus lesions and Leukocytes. Cytokine 2021;148:155696.

Ge, X.; Xie, H.; Nguyen, T.;et al.Promotes STAT4 Phosphorylation to Induce IL-17 Production in Keratinocytes of Oral Lichen Planus. iScience 2020;23:100983.

Lu, R.; Zeng, X.; Han, Q.;et al. Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus. Mediat. Inflamm. 2014;2014:701094.

Mahdavi, N.; Aminishakib, P.; Soltani, N. Presence of B Cells and Plasma Cells in Oral Lichen Planus. J. Dent. 2020;21:209–214.

.Scully C, el-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol. 1985 Jul;14(6):431-58.

Van den Haute V, Antoine JL, Lachapelle JM. Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica. 1989;179(1):10-3.

Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012 Feb 23;366(8):723-32. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991 Oct;25(4):593-619.

Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991 Oct;25(4):593-619.

Wagner G, Rose C, Sachse MM. Clinical variants of lichen planus. J Dtsch Dermatol Ges. 2013 Apr;11(4):309-19.

Warnakulasuriya S, Kovacevic T, Madden P, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011 Oct;40(9):677-83.

Ebrahimi M, Lundqvist L, Wahlin YB, Nylander E. Mucosal lichen planus, a systemic disease requiring multidisciplinary care: a cross-sectional clinical review from a multidisciplinary perspective. J Low Genit Tract Dis. 2012 Oct;16(4):377-80.

Gao XH, Barnardo MC, Winsey S, et al.The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol. 2005 Nov;125(5):895-9.

Setterfield JF, Neill S, Shirlaw PJ, et al.The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol. 2006 Jul;55(1):98-113.

Jacobsen AA, Tosti A. Trachyonychia and Twenty-Nail Dystrophy: A Comprehensive Review and Discussion of Diagnostic Accuracy. Skin Appendage Disord. 2016 Sep;2(1-2):7-13.

Gordon KA, Vega JM, Tosti A. Trachyonychia: a comprehensive review. Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):640-5.

Soares VC, Mulinari-Brenner F, Souza TE. Lichen planopilaris epidemiology: a retrospective study of 80 cases. An Bras Dermatol. 2015 Sep-Oct;90(5):666-70.

Errichetti E, Figini M, Croatto M, Stinco G. Therapeutic management of classic lichen planopilaris: a systematic review. Clin Cosmet Investig Dermatol. 2018;11:91-102.6.

Alaizari NA, Al-Maweri SA, Al-Shamiri HM,et al. Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2016 Sep;61(3):282-7.

Cook LC, Hanna C, Foulke GT, Seiverling EV. Dermoscopy in the Diagnosis of Inflammatory Dermatoses: Systematic Review Findings Reported for Psoriasis, Lupus, and Lichen Planus. J Clin Aesthet Dermatol. 2018 Apr;11(4):41-42.

.Tiwari SM, Gebauer K, Frydrych AM, Burrows S. Dental patch testing in patients with undifferentiated oral lichen planus. Australas J Dermatol. 2018 Aug;59(3):188-193.

.Orteu CH, Buchanan JA, Hutchison I,et al.Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed? Br J Dermatol. 2001 Jun;144(6):1219-23.

Atzmony L, Reiter O, Hodak E,et al.. Treatments for Cutaneous Lichen Planus: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2016 Feb;17(1):11-22.

Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011 Jul 06;(7):CD001168.

Motamed-Sanaye A,Khazaee YF,Shokrgozar M,et al.JAK inhibitors in lichen planus : a review of oathogenesis and treatment.J Dermatol Treat. 2022;33:3098-3103.

Mital R,Gray A,Minta A,et al.Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review.Dermatol and Ther 2023;13:77-94.

Seehafer JR, Rogers RS, Fleming CR, Dickson ER. Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis. Arch Dermatol. 1981 Mar;117(3):140-2.